HAIC Combined With Toripalimab and Donafenib for Advanced BTC

Clinical trial NCT05350943 · UNKNOWN

Trial details

NCT number: NCT05350943
Sponsor: Lu Wang, MD, PhD
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Adenocarcinoma

Start date: 2022-03-01
Primary completion: 2022-11-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.